期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | HYPERTENSION LetPub Score 9.0
50 ratings
Rate
Reputation 9.9 Influence 8.2 Speed 9.6 | ||||||||||||||||
期刊簡稱 | HYPERTENSION | ||||||||||||||||
ISSN | 0194-911X | ||||||||||||||||
E-ISSN | 1524-4563 | ||||||||||||||||
h-index | 246 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 4.30%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.ahajournals.org/journal/hyp | ||||||||||||||||
在線稿件提交 | https://hype-submit.aha-journals.org/cgi-bin/main.plex | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Lippincott Williams and Wilkins Ltd. | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1979 | ||||||||||||||||
每年文章數 | 248每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 17.97% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0194-911X%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: About 37.5% | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[HYPERTENSION] 的評論 | 撰寫評論 |
作者: duan_2020 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-03 08:26:46 評論於 Submitted on August 7th, it is still in the first round of review. The agonizing wait continues...(0) 讚! | duan_2020 |
作者: 舒兰小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-09 16:12:16 評論於 Same question, any results?(0) 讚! | 舒兰小仙女 |
作者: 坠星倩影 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-03 13:46:30 評論於 Second External Audit(0) 讚! | 坠星倩影 |
作者: 水月秀兰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-17 09:50:19 評論於 Please translate the following paragraph into English and Japanese, with the headings ":" and ":"(0) 讚! | 水月秀兰 |
作者: 风芹小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-12 22:59:50 評論於 Is it considered under external review if the status changes from submitted to under review to decision back to under review? Or is it being reviewed by the associate editor?(0) 讚! | 风芹小哥哥 |
作者: 风芹小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-12 16:19:43 評論於 Is it submitted--under review--decision--under review, that means it has been sent for external review? Or is it with the associate editor?(0) 讚! | 风芹小哥哥 |
作者: 是昕雨吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-21 19:39:46 評論於 Hello! I would like to ask how long it takes from online to formal publication, thank you(0) 讚! | 是昕雨吖 |
作者: 是昕雨吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-21 11:25:17 評論於 Hello! I would like to ask how long it takes from online to official publication, thank you(0) 讚! | 是昕雨吖 |
作者: 邻家飞跃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-06 23:53:07 評論於 Authoritative journal in the field of cardiovascular, difficult to submit, high quality articles required, need to have a certain level of innovation. Submission difficulty and article quality are both in the 7-9 range, without any superficial content. However, there is still a gap compared to CIRCULATION RESEARCH(0) 讚! | 邻家飞跃 |
作者: 子睿Sama 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-08 18:53:10 評論於 #Cardiovascular# Pulmonary hypertension, 1st review for 12 days with three reviewers, major revision, resubmitted after two months, 2nd review for 2 days, one reviewer had questions, resubmitted after 2 days, 3rd review for 1 day, accepted, publishing requires great innovation and effort, not easy!(0) 讚! | 子睿Sama |
作者: 华清阏逢 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-17 13:03:16 評論於 Help: I need to find a supplement to an article in this magazine, how can I do that?(0) 讚! | 华清阏逢 |
作者: 骨架雪磊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-12-04 12:15:28 評論於 Do you have the submission link of his? Can you share it with me?(0) 讚! | 骨架雪磊 |
作者: Oliver Jerry 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-25 21:59:26 評論於 High accuracy of hit rate(0) 讚! | Oliver Jerry |
作者: 落雁正业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-02-01 17:46:32 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Sharing experience: Rejected after 3 weeks of review, feeling down(0) 讚! | 落雁正业 |
作者: 东风采蓉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-25 19:56:30 評論於 Submission acceptance rate: 25.0 Experience sharing: I received an acceptance notification this morning. Hypertension is a very time-sensitive journal, with a review period of no more than 28 days. My article was given 3 months for minor revisions, with strict deadlines. If the article exceeds 3 months, it will be evaluated as a new submission. Our department has submitted a total of 15 articles from 2010 to now, with 3 accepted so far, which is close to the acceptance rate of this journal. Personally, I have submitted 2 articles, the first one in 2013. After a major revision and the requirement for further modifications, I gave up because I was facing my doctoral graduation at the time. Today's submission went smoothly, with minor revisions and feasible requests for additional experiments. It took about 2 months to complete all the required experiments, communicating solely through data(0) 讚! | 东风采蓉 |
作者: yuxiufeng0806@126.com 領域: 生命科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-01-25 13:28:15 評論於 Hypertension is a very time-sensitive journal. The review period is no longer than 28 days. My article was in minor revision for 3 months. Our department has submitted 15 articles from 2010 to the present, and currently had 3 articles accepted, which is close to the acceptance rate of this journal. (0) 讚! | yuxiufeng0806@126.com |
作者: pub 領域: 医药科学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2017-08-07 18:21:02 評論於 The problem of the external auditorA burst of blood, can not be evaded.It is very laborious to answer.It took 3 months to supplement the experiment, which was not delayed and the pressure was great.After the repair, the trial will be passed and received.(1) 讚! | pub |
作者: 一只珠玉呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-08-07 17:10:02 評論於 The questions from the external audit experts were incisive and could not be avoided. Answering them was very difficult. It took 3 months to complete the supplementary experiments, and there was no room for delay, so the pressure was high. After making revisions, it was re-audited and accepted(0) 讚! | 一只珠玉呀 |
作者: Christine Housman 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-21 08:11:22 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: The review speed is very fast, two weeks after submission, it was rejected with opinions from three reviewers(0) 讚! | Christine Housman |
作者: Nicola Cooke 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-04-07 19:08:56 評論於 Review speed: 3.0 | Submission acceptance rate: 25.0 Sharing experience: The latest published study on birth cohort, congenital heart research: The results of this study support and extend the findings of the early NBDPS, indicating a possible association between the use of antihypertensive medications and an increased risk of specific CHD, although we cannot completely rule out the confounding effects of potential disease characteristics(0) 讚! | Nicola Cooke |
作者: Nicola Cooke 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-04-07 12:03:46 評論於 Definitely not yet to external review. HSH1234 2016-03-13: Just submitted for one day, and the status changed to under review. Received an email (have begun the assignment/peer review process). As it's my first submission, I'd like to ask if this status means it has been sent out for review or if it's an initial editorial review. Please advise, thank you(0) 讚! | Nicola Cooke |
作者: Nicola Cooke 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-04-07 09:14:42 評論於 This issue should be dealt with rationally, and foreigners' programming thinking is very important. There are internal and external reviews, with technical review first and peer review later. The criteria examined at each level are different(0) 讚! | Nicola Cooke |
作者: qiye 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2017-02-07 15:49:30 評論於 One of the seven major flagship journals of the American Heart Association.The top mark journal in the field of cardiovascular research, the reviewers are all big cattle in the field, and the articles are more than the circulation research every year, but the review ratio is very low, so the impact factor is about 7 in recent years.There are few articles made in pure China, and research requires a combination of basic clinical methods, and model animals are often used.At the same time, research results need to be strongly innovative.The reviewer's question is sharp and unambiguous. It can be published in this journal. It has already explained the level of research and is a journal with great influence in the cardiovascular field.Articles charge a page fee, see the journal faster!The receiving ratio should be less than 10%.(7) 讚! | qiye |
作者: 金蛇怡君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-01-17 14:19:24 評論於 Hello, may I ask if this magazine charges for page fees? Anonymous, July 18, 2014: Research interests: epidemiology; clinical research; acceptance rate: about 5%; review time: about 1 month. Submitted an article on June 25th, on clinical aspects, with a relatively large sample size. Received first review in 14 days, with 2 reviewers requested. The first reviewer highly praised our research, only suggesting that we find a native English speaker to polish the language. The second reviewer raised 5 minor issues, including language and some very small details. Spent 2500 yuan on language editing, carefully answering the reviewers' questions, and resubmitted after 1 week. 2 days later, it was rejected, stating that although the research was good and the reviewers had no objections, it did not meet the priority conditions for publication. I have replied asking why we were asked to revise if the research did not meet the conditions for publication. Could it be just for the so-called language editing fee? I suggest to comrades, don't be fooled again. In the future, regardless of the journal, language should be the final thing to be modified. Let the editor check everything else first. If everything is okay, only then consider the language issue. It's not a big deal if it's just a language issue. Chinese-written SCIs are often criticized by foreigners for language issues, and you know the reason – the profits of the language editing companies. Although it failed, there are lessons learned to be shared with comrades(0) 讚! | 金蛇怡君 |
作者: 金蛇怡君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-01-17 13:19:28 評論於 Hello, could you please let me know if there is a page fee for this magazine?(0) 讚! | 金蛇怡君 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us